3D printing is providing exciting technological possibilities for industry by creating the concept of personalized medical devices, models for clinical trials, and other possibilities. How is FDA’s regulation of 3D printers and printed medical devices both similar and different from that of other devices?

Intervenants: Farah Tabibkhoei

Type d’évènement: Conférence

Lieu
Genentech, B82, 651 Gateway Blvd , South San Francisco CA 94080
Date/heure de début
6 June 2019
Date/heure de fin
6 June 2019
The panel, including Reed Smith's Farah Tabibkhoei, will discuss how companies can successfully navigate FDA regulation of this technology, as well as address the all‑important reimbursement issues.